Dapagliflozin (DAPA) Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Also known as: Dapagliflozin

Pipeline

Phase 3: 1Phase 4: 1

Top Sponsors

Junjie Yang1
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1

Indications

Diabetes2
Heart Disease1
Type 2 Diabetes Mellitus (T2DM)1
Coronary Artery Disease1
Atherosclerosis1

Other2 trials

A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Phase 3

SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.